Hannover Rueck SE (0M9A)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 281.00 |
|---|---|
| 52-week range | 224.00 – 282.40 |
| Return, 1 month / 3 months | +11.0% / +13.0% |
| Return, 1 year / 3 years | +15.6% / +48.9% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 18.8% |
| Worst drawdown (1 year) | -15.0% |
| Average daily value traded | 7.72M EUR |
| Dividend yield | 4.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hannover Rueck SE is a reinsurance company based in Hannover, Germany. It takes on risks from primary insurers, covering property and casualty business as well as life and health reinsurance. Its customers are insurance companies around the world that transfer part of their risk to the reinsurer. The company also offers services in areas such as risk management and structured reinsurance solutions for its clients.
On this site Hannover Rueck SE appears as a stock on the London Exchange (UK), code 0M9A, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hannover Rueck SE (0M9A) trades on the London Exchange in UK. It last closed at EUR 281.00 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 253 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.6% and over the last three months it rose 13.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.8% | ||
| From 52-week high | -0.5% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.0% | ||
| 6-month return | 7.5% | ||
| 12-month return, skipping the last month | 4.2% | ||
| Stability (higher is calmer) | 87 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.0% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 7.72M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | +11.0% |
| 3 months | +13.0% |
| 6 months | +7.5% |
| 1 year | +15.6% |
| 3 years | +48.9% |
| 5 years | +105.1% |
Signals
| 50-day / 200-day average | 258.99 / 246.83 |
|---|---|
| Golden / death cross (60 days) | Golden, 52 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | EUR 12.5000 |
| 8 May 2025 | EUR 2.0000 |
| 7 May 2024 | EUR 6.0000 |
| 4 May 2023 | EUR 1.0000 |
| 5 May 2022 | EUR 4.5000 |
| 6 May 2021 | EUR 4.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.